Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
from Industrial Alliance Securities issued a price target of $2.50 for OPAD on 2026-02-24 18:25:53.The adjusted price target was set to $2.50.At the time of the announcement,
February 24, 2026 OPAD -2.46%
Yi Chen from H.C. Wainwright issued a price target of $12.00 for DRTS on 2026-02-24 15:29:33.The adjusted price target was set to $12.00.At the time of the announcement,
February 24, 2026 DRTS 0.68%
from Wedbush issued a price target of $1.00 for GOSS on 2026-02-24 12:45:05.The adjusted price target was set to $1.00.At the time of the announcement, GOSS was...
February 24, 2026 GOSS -5.08%
from Leerink Partners issued a price target of $50.00 for XOMA on 2026-02-24 11:08:45.The adjusted price target was set to $50.00.At the time of the announcement, XOMA...
February 24, 2026 XOMA 6.56%
Lee Horowitz from Deutsche Bank issued a price target of $23.00 for LIFE on 2026-02-24 09:33:16.The adjusted price target was set to $23.00.At the time of the announcement,
February 24, 2026 XOMA 6.56%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| CDIOW Cardio Diagnostics Holdin | 0.04
61.51% | ||||||||||||||||||
| LRMR Larimar Therapeutics, Inc | 3.69
31.46% | ||||||||||||||||||
| TBMC Trailblazer Merger Corpor | 12.79
26.53% | ||||||||||||||||||
| JSPRW Jasper Therapeutics Inc | 0.02
22.84% | ||||||||||||||||||
| AXTI AXT, Inc. | 34.85
22.58% | ||||||||||||||||||
| SGMO Sangamo Therapeutics, Inc | 0.48
22.01% | ||||||||||||||||||
| MAPSW WM Technology Inc | 0.01
21.31% | ||||||||||||||||||
| HRTG Heritage Insurance Holdin | 27.70
18.05% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 7.81%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 10.12%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -1.26%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 2.06%